65,437 trials
Pain, Postoperative
Primary: Assessing Change in Pain Using the Visual Analogue Scale (VAS) Pain Score — 2.90; 3.51; 2.36; 2.40 score on a scale
Healthy
Primary: Ketone Production — 217.71; 187.48 µmol/L
Anesthesia, General
Primary: Time From Start of Sugammadex Administration to Recovery of the Neuromuscular Response to a Ratio of 0.9 for Train-Of-Four (TOF) Stimulation — 66.90; 4.73; 3.43; 1.58…
Shigella Sonnei Infection
Primary: Number of Subjects With Solicited Local and Systemic Adverse Reactions After Each Vaccination — 21; 25; 21; 21 Participants
Coronary Artery Disease
Primary: Number of Participants With Detected Stress-induced Perfusion Abnormalities by 3D Analysis of MDCT Images — 56 Participants
Chronic Obstructive Pulmonary Disease · Heart Failure · Sickle Cell Disease
Primary: PROMIS Emotional Distress-Anxiety (v1.0, SF4a) — -0.2; -1.7 T-score
HIV-1 Infection
Primary: Percentage Change From Baseline in HIV-1 Ribonucleic Acid (RNA) Viral Load — -1.52; -1.41; -0.15 Percentage change — p=<0.001
Dermatitis, Atopic
Primary: Number of Participants With Treatment-related Adverse Events (AEs) — 1; 3; 2; 6 Participants
Hepatitis C
Primary: Evaluation of Safety. — 6; 8; 9; 8 Participants
Healthy Subjects
Primary: Change in Functional Connectivity Strength Measured With Functional Magnetic Resonance Imaging — .25; .13 correlation coefficient
Metastatic Gastric Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma
Primary: Progression Free Survival (PFS) — 6.34; 6.74 Months — p=0.698
Cancer
Primary: Maximum Tolerated Dose (MTD) of IMC-RON8 — NA mg/kg
Overactive Bladder (OAB)
Primary: Change From Baseline to End of Treatment (EOT) in Mean Number of Micturitions Per 24 Hours — -1.7; -2.3 micturitions/24 hours — p=<0.001
Chronic Obstructive Pulmonary Disease
Primary: Number of Participants With ≥1 Treatment Emergent Adverse Event in Any Category. — 3; 1; 5; 4 Participants
Cheek Line Depressions
Primary: Percentage of Participants by Improvement Rating (Improved and Not Improved) of Their Dynamic Radial Cheek Lines as Assessed by the Participant Using the Global…